Supplier
America's Best Care Plus, INC.
America's Best Care Plus, INC. was paid $706K by Medicaid between Jan 2018 and Dec 2024, across 16 billing codes. Its largest line is Q0513, Pharmacy dispensing fee for inhalation drug(s); per 30 days — 15% of everything it billed.
33Billing provider infoAMERICA'S BEST CARE PLUS, INC.
FORT PAYNE, AL 35968
FORT PAYNE, AL 35968
33aNPI1912060740assigned 12/19/2006
33bProvider typeMail Order Pharmacy
28Total paid$706K
24GClaims176,421
24DCodes billed16
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,488 | $100K | |
| 2019 | 36,524 | $123K | |
| 2020 | 33,119 | $137K | |
| 2021 | 26,457 | $141K | |
| 2022 | 22,979 | $106K | |
| 2023 | 15,840 | $67K | |
| 2024incomplete | 11,014 | $32K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 15% | 44,988 | 41,846 | $108K |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 15% | 4,527 | 4,199 | $104K |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 15% | 24,094 | 22,304 | $104K |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | 15% | 1,177 | 1,091 | $103K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 12% | 19,423 | 18,216 | $85K |
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | 11% | 2,031 | 1,856 | $81K |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | 6.6% | 390 | 358 | $46K |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | 4.8% | 31,983 | 29,976 | $34K |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 2.4% | 3,390 | 3,117 | $17K |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | 2.1% | 28,998 | 27,106 | $15K |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 11,725 | 11,055 | $6K |
| E0570 | Nebulizer, with compressor | <1% | 1,653 | 1,553 | $2K |
4 more codes
| 99199 | Unlisted special service, procedure or report | <1% | 87 | $930.59 |
| A7013 | Filter, disposable, used with aerosol compressor or ultrasonic generator | <1% | 1,596 | $505.85 |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 282 | $395.69 |
| G0333 | Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary | <1% | 77 | $153.77 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANCOCK, CHARMAN (DIRECTOR OF OPERATIONS)